ID   TSGH-8302
AC   CVCL_N030
SY   TSGH8302; TSGH 8302; Tri-Service General Hospital-8302
DR   ChEMBL-Cells; CHEMBL3307472
DR   ChEMBL-Targets; CHEMBL615019
DR   PubChem_Cell_line; CVCL_N030
DR   Wikidata; Q54973127
RX   PubMed=1855216;
RX   PubMed=21607305;
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
RX   PubMed=21607305; DOI=10.3892/or.1.1.53;
RA   Wu, Felicia Ying-Hsiueh
RA   Chang, Wen-Tsan
RA   Sun, Te-Ping
RT   "Vitamin-K-3 induces cell-death via apoptosis in human
RT   cervical-carcinoma TSGH8302 cells.";
RL   Oncol. Rep. 1:53-58(1994).
//
RX   PubMed=1855216;
RA   Roffler, Steve R.
RA   Yu, Mu-Hsien
RA   Chen, Bing Mae
RA   Tung, Edward
RA   Yeh, Ming-Yang
RT   "Therapy of human cervical carcinoma with monoclonal
RT   antibody-Pseudomonas exotoxin conjugates.";
RL   Cancer Res. 51:4001-4007(1991).
//